CDSCO’s MD-14 checklist lists 20 categories of Device Master File evidence and requests the latest competent-authority inspection or audit report from the previous three years, if available. Therefore, companies cannot treat medical devices registration in India as a simple form-filling exercise. A strong medical device registration strategy must align classification, authorization, validation, labeling, and post-market records. As a result, applicants can reduce preventable regulatory queries and approval delays.
Table of Contents
What Is Medical Devices Registration in India?
Medical devices registration in India defines how manufacturers and importers can legally place a device on the Indian market. First, CDSCO classifies each device as Class A, B, C, or D based on risk. Then, the applicant selects the correct licence, submits the required technical documents, and follows the Medical Devices Rules 2017. Foreign manufacturers must also appoint an eligible Indian Authorized Agent. Therefore, accurate classification, complete evidence, and the correct application route help prevent regulatory queries and approval delays.
Why CDSCO Readiness Matters for Quality Compliance?
CDSCO readiness matters because regulators compare quality records, technical files, labels, validation data, and manufacturing details for consistency. Therefore, companies must connect each claim to clear evidence and maintain accurate documentation throughout the product lifecycle. In addition, strong records help reviewers understand the device, assess its risks, and verify compliance with the Medical Devices Rules 2017. As a result, applicants can reduce avoidable queries, inspection concerns, and approval delays.
Four Decisions That Shape the Approval Pathway
A successful CDSCO submission starts with four critical decisions. First, applicants must confirm the device class and regulatory route. They must also appoint the right Indian representative, select the correct form, and prepare consistent technical evidence. Therefore, resolving these points early can reduce regulatory queries and approval delays.
The following four steps define the correct CDSCO approval pathway:
- Confirm the Device’s Risk Class (PDF)
- Confirm the Indian Authorized Agent (PDF)
- Match the Route to the Correct CDSCO Form (PDF)
- Build an Inspection-Ready Technical Dossier (PDF)
Confirm the Device’s Risk Class (PDF)
CDSCO classifies devices as Class A, B, C, or D based on risk. The class determines the licensing route and regulatory authority.
Download CDSCO Medical Devices FAQ on Risk Classification Here
Confirm the Indian Authorized Agent (PDF)
Foreign manufacturers must appoint an eligible Indian Authorized Agent. The agent must hold valid authorization and submit the CDSCO application.
Download Medical Devices Rules 2017: Authorized Agent and Power of Attorney Requirements Here
Match the Route to the Correct CDSCO Form (PDF)
Applicants must select the correct form for the device class and activity. For example, Form MD-14 leads to Form MD-15 for imports.
Download CDSCO Checklist for Form MD-7 and Form MD-9 Manufacturing Licence Here
Build an Inspection-Ready Technical Dossier (PDF)
The dossier must align quality, technical, validation, labeling, and post-market records. Consistent evidence can reduce queries and inspection concerns.
Download CDSCO MD-14 Checklist for the Form MD-15 Import Licence Here
The infographic below shows the key documents and evidence required to build an inspection-ready CDSCO dossier.
How the CDSCO Submission and Approval Process Works
The CDSCO approval process starts with device classification and route selection. Next, the applicant chooses the correct form, prepares the required technical documents, and submits the application through the relevant online portal. CDSCO then reviews the dossier, raises queries when needed, and may inspect the manufacturing site. Therefore, complete records and accurate responses help applicants move from submission to licence issuance with fewer delays.
The infographic below maps the key documents and evidence needed for an inspection-ready CDSCO medical device dossier.
Common Deficiencies That Delay Approval
Even a technically sound device can face delays when the dossier tells an inconsistent story. CDSCO reviewers compare classification, authorization, quality records, technical files, labels, validation data, and post-market evidence. Therefore, missing or conflicting information can trigger regulatory queries and extend the review. In addition, major evidence gaps may increase inspection scrutiny before licence issuance.
The table below links common dossier deficiencies to the regulatory concerns they may create.
| Common deficiency | What CDSCO expects | Possible review impact |
|---|---|---|
|
Incorrect device classification |
A risk class that matches the intended use and CDSCO criteria |
Correction of the class, form, or licensing route |
|
Incomplete Power of Attorney |
Valid authorization between the manufacturer and Indian Authorized Agent |
Queries about applicant authority and legal responsibility |
|
Inconsistent PMF and DMF data |
Matching manufacturing-site, product, and quality-system information |
Additional questions or increased inspection scrutiny |
|
Incomplete validation evidence |
Required software, sterilization, biocompatibility, and process validation |
Requests for additional technical evidence |
|
Label and intended-use differences |
Consistent claims across labels, Instructions for Use, and technical documents |
Delays caused by product identity or classification concerns |
Final Words
CDSCO guidance sets a 60-day period for inspecting Class C and Class D manufacturing sites after application submission. Therefore, companies pursuing medical devices registration in India should align their QMS, technical dossier, labels, validation records, and site practices before filing. As regulatory reviews become more evidence-driven, consistent records remain the strongest protection against inspection concerns and approval delays.
Medical Devices & IVDs EU Registration
We guide companies through medical device and IVD EU registration by supporting MDR and IVDR requirements, technical documentation, and structured processes for compliant market access.
FAQ
Check the device’s intended use, invasiveness, duration of contact, and risk level under the Medical Devices Rules 2017. The final class determines the application form, licensing authority, and review requirements.
No. A foreign manufacturer must appoint an eligible Indian Authorized Agent to submit Form MD-14, communicate with CDSCO, and maintain regulatory responsibility in India.
Common delays come from inconsistent labels, incomplete validation, weak clinical evidence, incorrect classification, and mismatched Plant Master File and Device Master File data. Quality and regulatory teams should resolve these gaps before submission.
References
Alireza Zarei is the founder and CEO of Zamann Pharma Support GmbH in Germany. He pairs 20 years in GMP—beginning in a lab in 2005—with front-line global project delivery for companies such as Boehringer Ingelheim, Roche, BioNTech, Takeda, Fresenius Medical Care, Biotest, ratiopharm and others. He focuses on innovative validation and qualification procedures, master data management strategies, end-to-end LIMS implementation and care, with pragmatic advice on general Quality Management topics and management level OpEx consulting. Together with his team he also created Pharmuni.com as the leading GMP learning platform in the industry.